Close

Farmacos Covid19

Regeneron Says Its COVID-19 Antibody Drug Could Be Less Effective Against Omicron

Regeneron Pharmaceuticals Inc’s COVID-19 antibody treatment and other similar drugs could be less effective against the new Omicron coronavirus variant, the company said on Tuesday. The drugmaker said further analyses are ongoing to confirm and quantify this potential impact using the actual Omicron variant sequence. Global markets fell on Tuesday […]

Read More

Severe COVID-19 Doubles Risk of Dying in Following Year: Study

Patients who survive a severe case of COVID-19 are more than twice as likely to die during the following year than those who have mild symptoms and those who haven’t been infected, according to a new study published Wednesday in the journal Frontiers in Medicine. The increased risk was greater for patients under […]

Read More

Study reveals acute effects of severe COVID-19 on the brain

A large international study suggests that around 1 in every 100 patients hospitalized with COVID-19 have brain complications. These include stroke, brain hemorrhage, and other potentially fatal conditions. Many of the patients had preexisting illnesses, such as high blood pressure, heart disease, and diabetes. Previous research has shown that some people who recover from […]

Read More

Morbimortalidad por COVID-19, eficacia de la vacuna BNT162b2 en niños, y características de riesgo de muerte por SARS-CoV-2

En esta sección estarán disponibles los resúmenes de artículos recientes, publicados en las principales revistas científicas de pediatría, analizados por el Dr. Jesús Hernández. El Dr. Hernández Tiscareño es egresado de la Benemérita Universidad Autónoma de Puebla y de la Universidad Nacional Autónoma de México, donde cursó un posgrado en […]

Read More

Measuring Viral RNA Can Identify COVID-19 Patients Most at Risk of Dying

The amount of a SARS-CoV-2 genetic material—viral RNA—in the blood is a reliable indicator in detecting which patients will die of the disease, a team led by Université de Montréal medical professor Dr. Daniel Kaufmann has found. The finding is published today in Science Advances. Kaufmann and his team did the work at […]

Read More

More Countries Report Cases of New Omicron Variant

The United Kingdom, Italy, Germany, Belgium and Australia reported their first cases of the new Omicron variant during the weekend, joining a growing list of countries that have confirmed cases among travelers returning from southern Africa. The U.S. hasn’t detected the variant yet, but it’s possible that it could already […]

Read More

COVID-19: el resumen semanal (19 al 25 de noviembre de 2021)

Sublinaje de delta AY.4.2 y nueva variante en Sudáfrica El sublinaje o subvariante de delta AY.4.2, responsable de 12% de los aislamientos secuenciados en Reino Unido y ya detectado en cuatro decenas de países, parece ser algo más transmisible que el linaje dominante de delta (AY.4), pero solo un tercio de […]

Read More

Ómicron: los síntomas de la nueva variante de covid-19, según la médica que la descubrió en Sudáfrica

La doctora Angelique Coetzee, presidenta de la Asociación Médica de Sudáfrica, dijo que hasta ahora los pacientes contagiados con la nueva variante ómicron del coronavirus causante de la covid han presentado síntomas muy leves. “Lo que estamos viendo ahora en Sudáfrica, y recuerden que estoy en el epicentro, es extremadamente leve“, […]

Read More